|
US5541110A
(en)
*
|
1994-05-17 |
1996-07-30 |
Bristol-Myers Squibb |
Cloning and expression of a gene encoding bryodin 1 from Bryonia dioica
|
|
IT1275909B1
(it)
*
|
1995-03-07 |
1997-10-24 |
Mirella Pilone |
Frammento di dna codificante d-amminoacido ossidasi
|
|
US7560534B2
(en)
|
2000-05-08 |
2009-07-14 |
Celldex Research Corporation |
Molecular conjugates comprising human monoclonal antibodies to dendritic cells
|
|
CN1152051C
(zh)
*
|
2000-08-02 |
2004-06-02 |
北京翔天牧生物科技有限公司 |
一种天花粉蛋白突变体及制备方法
|
|
IL159944A0
(en)
*
|
2001-07-19 |
2004-06-20 |
Yissum Res Dev Co |
Polypeptides having carotenoid isomerase catalytic activity, nucleic acids encoding same and uses thereof
|
|
US20060008464A1
(en)
*
|
2002-04-08 |
2006-01-12 |
Chaim Gilon |
Histone conjugates and uses thereof
|
|
CA2489153A1
(en)
*
|
2002-06-11 |
2003-12-18 |
Merck Patent Gesellschaft Mit Beschraenkter Haftung |
Modified byrodin 1 with reduced immunogenicity
|
|
US20060009378A1
(en)
|
2002-11-14 |
2006-01-12 |
Itshak Golan |
Novel galectin sequences and compositions and methods utilizing same for treating or diagnosing arthritis and other chronic inflammatory diseases
|
|
WO2004074432A2
(en)
*
|
2003-01-31 |
2004-09-02 |
Celldex Therapeutics, Inc. |
Antibody vaccine conjugates and uses therefor
|
|
US9259459B2
(en)
*
|
2003-01-31 |
2016-02-16 |
Celldex Therapeutics Inc. |
Antibody vaccine conjugates and uses therefor
|
|
US7294701B2
(en)
*
|
2003-04-02 |
2007-11-13 |
Technion Research & Development Foundation Ltd. |
Antibody fragment capable of modulating multidrug resistance and compositions and kits and methods using same
|
|
WO2004108882A2
(en)
*
|
2003-06-11 |
2004-12-16 |
Yeda Research And Development Co. Ltd. |
Neural stem cells and methods of generating and utilizing same
|
|
WO2005081632A2
(en)
*
|
2004-02-26 |
2005-09-09 |
State Of Israel, Ministry Of Agriculture, Agricultural Research Organization |
Enzymes, cells and methods for site specific recombination at asymmetric sites
|
|
US20140113860A1
(en)
|
2006-02-03 |
2014-04-24 |
Prolor Biotech Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
|
US10221228B2
(en)
|
2006-02-03 |
2019-03-05 |
Opko Biologics Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
|
US7553941B2
(en)
|
2006-02-03 |
2009-06-30 |
Modigene Inc |
Long-acting polypeptides and methods of producing same
|
|
US8048848B2
(en)
|
2006-02-03 |
2011-11-01 |
Prolor Biotech Ltd. |
Long-acting interferons and derivatives thereof and methods thereof
|
|
US10351615B2
(en)
|
2006-02-03 |
2019-07-16 |
Opko Biologics Ltd. |
Methods of treatment with long-acting growth hormone
|
|
US8759292B2
(en)
|
2006-02-03 |
2014-06-24 |
Prolor Biotech, Llc |
Long-acting coagulation factors and methods of producing same
|
|
US8476234B2
(en)
|
2006-02-03 |
2013-07-02 |
Prolor Biotech Inc. |
Long-acting coagulation factors and methods of producing same
|
|
US8450269B2
(en)
|
2006-02-03 |
2013-05-28 |
Prolor Biotech Ltd. |
Long-acting growth hormone and methods of producing same
|
|
US8946155B2
(en)
|
2006-02-03 |
2015-02-03 |
Opko Biologics Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
|
US9249407B2
(en)
|
2006-02-03 |
2016-02-02 |
Opko Biologics Ltd. |
Long-acting coagulation factors and methods of producing same
|
|
US20150038413A1
(en)
|
2006-02-03 |
2015-02-05 |
Opko Biologics Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
|
US9458444B2
(en)
|
2006-02-03 |
2016-10-04 |
Opko Biologics Ltd. |
Long-acting coagulation factors and methods of producing same
|
|
US8048849B2
(en)
|
2006-02-03 |
2011-11-01 |
Modigene, Inc. |
Long-acting polypeptides and methods of producing same
|
|
CA2682093A1
(en)
|
2007-03-29 |
2008-10-09 |
Technion Research & Development Foundation Ltd. |
Antibodies, methods and kits for diagnosing and treating melanoma
|
|
US8236318B2
(en)
|
2007-11-07 |
2012-08-07 |
Celldex Therapeutics Inc. |
Antibodies that bind human dendritic and epithelial cell 205 (DEC-205)
|
|
JP2012522762A
(ja)
|
2009-04-01 |
2012-09-27 |
ザ メディカル リサーチ, インフラストラクチャー, アンド ヘルス サーヴィシーズ ファンド オブ ザ テル アヴィヴ メディカル センター |
ケラチノサイトの増殖および分化を調節する方法
|
|
US9663778B2
(en)
|
2009-07-09 |
2017-05-30 |
OPKO Biologies Ltd. |
Long-acting coagulation factors and methods of producing same
|
|
US12203113B2
(en)
|
2009-07-09 |
2025-01-21 |
Opko Biologics Ltd. |
Long-acting coagulation factors and methods of producing same
|
|
AU2011219426A1
(en)
|
2010-02-24 |
2012-10-04 |
Ben Gurion University Of The Negev Research And Development Authority |
Methods for inhibiting necrosis
|
|
US9267142B2
(en)
|
2010-03-08 |
2016-02-23 |
Yeda Research And Development Co. Ltd. |
Recombinant protein production in heterologous systems
|
|
EP2556085A2
(de)
|
2010-04-05 |
2013-02-13 |
Bar-Ilan University |
Proteaseaktivierbare, porenbildende polypeptide
|
|
WO2011128895A2
(en)
|
2010-04-12 |
2011-10-20 |
Ben Gurion University Of The Negev Research And Development Authority |
Sulfotransferase of a red microalga and uses thereof
|
|
US20130053277A1
(en)
|
2010-05-04 |
2013-02-28 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods of identifying inhibitors of polypeptides-of-interest
|
|
US20130164288A1
(en)
|
2010-09-07 |
2013-06-27 |
Protalix Ltd. |
Readthrough acetylcholinesterase (ache-r) for treating or preventing parkinson's disease
|
|
WO2012046238A2
(en)
|
2010-10-06 |
2012-04-12 |
Ramot At Tel-Aviv University Ltd. |
Erythropoietin receptor antagonists
|
|
WO2012052878A1
(en)
|
2010-10-19 |
2012-04-26 |
Vascular Biogenics Ltd. |
Isolated polynucleotides and nucleic acid constructs for directing expression of a gene-of-interest in cells
|
|
WO2012059925A2
(en)
|
2010-11-04 |
2012-05-10 |
Ben-Gurion University Of The Negev Research And Development Authority |
Acyl-coa: diacylglycerol acyltransferase 1-like gene (ptdgat1) and uses thereof
|
|
WO2012153333A1
(en)
|
2011-05-09 |
2012-11-15 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Regeneration and repair of mesenchymal tissue using amelogenin
|
|
WO2012153336A2
(en)
|
2011-05-12 |
2012-11-15 |
Rakuto Bio Technologies Ltd. |
Methods and device for lightening skin complexion
|
|
WO2012156976A1
(en)
|
2011-05-16 |
2012-11-22 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods of producing artemisinin in non-host plants and vectors for use in same
|
|
WO2012160526A2
(en)
|
2011-05-23 |
2012-11-29 |
Ofir Menashe |
Formulations of microorganism comprising particles and uses of same
|
|
US10166295B2
(en)
|
2011-06-02 |
2019-01-01 |
Opko Biologics Ltd. |
Pegylated OXM variants
|
|
WO2013050966A2
(en)
|
2011-10-05 |
2013-04-11 |
Ben Gurion University Of The Negev Research And Develpment Authority |
Compositions and methods for conferring herbicide resistance
|
|
WO2013114363A2
(en)
|
2012-01-30 |
2013-08-08 |
Yeda Research And Development Co.Ltd. |
Antimicrobial agents
|
|
PE20142290A1
(es)
|
2012-02-14 |
2015-01-15 |
Opko Biolog Ltd |
Factores de coagulacion de accion prolongada y metodos de produccion de los mismos
|
|
EP2844744A2
(de)
|
2012-02-22 |
2015-03-11 |
Brainstem Biotec Ltd. |
Microrns zur erzeugung von astrocyten
|
|
WO2013124816A2
(en)
|
2012-02-22 |
2013-08-29 |
Brainstem Biotec Ltd. |
Generation of neural stem cells and motor neurons
|
|
WO2013157002A1
(en)
|
2012-04-19 |
2013-10-24 |
Prolor Biotech Inc. |
Long-acting oxyntomodulin variants and methods of producing same
|
|
MX362432B
(es)
|
2012-06-04 |
2019-01-17 |
Opko Biologics Ltd |
Variantes de oxm pegilada.
|
|
SG11201503879QA
(en)
|
2012-11-20 |
2015-06-29 |
Opko Biolog Ltd |
Method of increasing the hydrodynamic volume of polypeptides by attaching to gonadotrophin carboxy terminal peptides
|
|
CN105531365A
(zh)
|
2013-04-23 |
2016-04-27 |
耶达研究及发展有限公司 |
分离的幼稚多能干细胞和产生所述细胞的方法
|
|
BR112015029815B1
(pt)
|
2013-05-27 |
2020-06-30 |
Rakuto Bio Technologies Ltd |
Composição cosmética para clarear uma pele e/ou cabelo de um indiví$#205;duo e conjunto para clarear uma pele e/ou cabelo de um indivíduo
|
|
EP3004154A4
(de)
|
2013-06-05 |
2017-01-04 |
Ben Gurion University of The Negev Research and Development Authority |
Il-1-betta-il-1ra-chimäre und verfahren zur verwendung davon
|
|
HUE050002T2
(hu)
|
2013-10-21 |
2020-11-30 |
Opko Biologics Ltd |
Hosszan ható polipeptidek és eljárás azok elõállítására és beadására
|
|
US20150158926A1
(en)
|
2013-10-21 |
2015-06-11 |
Opko Biologics, Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
|
CN122465832A
(zh)
|
2014-07-30 |
2026-07-28 |
耶达研究及发展有限公司 |
用于培养多能干细胞的培养基
|
|
WO2016079736A2
(en)
|
2014-11-17 |
2016-05-26 |
Yeda Research And Development Co. Ltd. |
Methods of treating diseases related to mitochondrial function
|
|
KR102527180B1
(ko)
|
2014-12-10 |
2023-04-27 |
옵코 바이오로직스 리미티드 |
장기간 작용성 ctp-변형된 성장 호르몬 폴리펩타이드의 제조 방법
|
|
NZ733912A
(en)
|
2015-01-04 |
2023-04-28 |
Protalix Ltd |
Modified dnase and uses thereof
|
|
WO2016193969A2
(en)
|
2015-05-29 |
2016-12-08 |
Opko Biologics Ltd. |
Pegylated oxyntomodulin variants
|
|
KR102662956B1
(ko)
|
2015-06-19 |
2024-05-03 |
옵코 바이오로직스 리미티드 |
장기-작용성 응고 인자 및 그의 제조 방법
|
|
US10639350B2
(en)
|
2015-08-10 |
2020-05-05 |
The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center |
Methods and pharmaceutical compositions for improving wound healing using CD24
|
|
IL241462A0
(en)
|
2015-09-10 |
2015-11-30 |
Yeda Res & Dev |
Heterologous engineering of betalain pigments in plants
|
|
EP3355911B1
(de)
|
2015-09-30 |
2022-11-02 |
Hadasit Medical Research Services And Development Limited |
Verwendung von volllängen-amelogenin zur förderung des nervenwachstums oder der nervenregeneration
|
|
US20190083642A1
(en)
|
2016-03-30 |
2019-03-21 |
Regentis Biomaterials Ltd. |
Treatments utilizing a polymer-protein conjugate
|
|
EP3468610A1
(de)
|
2016-06-09 |
2019-04-17 |
OPKO Biologics Ltd. |
Langwirkende oxyntomodulinformulierung und verfahren zur herstellung und verabreichung davon
|
|
CN109689086A
(zh)
|
2016-07-11 |
2019-04-26 |
国家生物技术研究所公司 |
具有延长的血清半衰期的融合蛋白
|
|
EP4303228B1
(de)
|
2016-07-11 |
2026-05-27 |
OPKO Biologics Ltd. |
Langwirkender gerinnungsfaktor vii und verfahren zur herstellung davon
|
|
EP3484517B1
(de)
|
2016-07-18 |
2025-07-02 |
Ramot at Tel-Aviv University Ltd. |
Modulare plattform für gezielte therapeutika
|
|
IL247369B
(en)
|
2016-08-18 |
2018-08-30 |
B G Negev Tech And Applications Ltd |
Polypeptides derived from CSF-m and their uses
|
|
CN110234765A
(zh)
|
2016-11-28 |
2019-09-13 |
耶达研究及发展有限公司 |
分离的多核苷酸和多肽及使用它们来表达感兴趣的表达产物的方法
|
|
ES2916217T3
(es)
|
2017-01-05 |
2022-06-29 |
Kahr Medical Ltd |
Una proteína de fusión SIRP1 ALPHA-41BBL y métodos de uso de la misma
|
|
DK3565579T3
(da)
|
2017-01-05 |
2023-09-04 |
Kahr Medical Ltd |
Pd1-41bbl-fusionsprotein og fremgangsmåder til anvendelse deraf
|
|
IL250799A0
(en)
|
2017-02-26 |
2017-04-30 |
The Nat Inst For Biotechnology In The Negev Ltd |
Soluble chimeras of dr3 and pro-pilot ether and their use
|
|
WO2018229767A1
(en)
|
2017-06-13 |
2018-12-20 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods for improving cell protein production yields
|
|
US11692166B2
(en)
|
2017-08-23 |
2023-07-04 |
Technion Research & Development Foundation Limited |
Compositions and methods for improving alcohol tolerance in yeast
|
|
US11246912B2
(en)
|
2017-08-30 |
2022-02-15 |
Hadasit Medical Research Services & Development Ltd. |
Methods for treating and diagnosing metastatic liver cancer
|
|
IL257269A
(en)
|
2018-01-31 |
2018-04-09 |
Olender Tsviya |
Signaling is directed to the endoplasmic reticulum
|
|
DK3774859T3
(da)
|
2018-04-11 |
2024-05-27 |
Salubris Biotherapeutics Inc |
Sammensætninger af rekombinante fusionsproteiner af human neuregulin-1 (nrg-1) og fremgangsmåder til anvendelse deraf
|
|
CA3104780A1
(en)
|
2018-07-11 |
2020-01-16 |
Kahr Medical Ltd. |
Sirpalpha-4-1bbl variant fusion protein and methods of use thereof
|
|
US12441776B2
(en)
|
2018-11-30 |
2025-10-14 |
Eirgen Pharma Ltd. |
Oxyntomodulin peptide analog formulations
|
|
IL265486A
(en)
|
2019-03-19 |
2020-09-30 |
Yeda Res & Dev |
Type II stable opsins and methods of using them
|
|
BR112022000319A2
(pt)
|
2019-07-11 |
2022-03-15 |
Kahr Medical Ltd |
Heterodímeros e métodos de uso dos mesmos
|
|
US12668621B2
(en)
|
2019-07-16 |
2026-06-30 |
Ramot At Tel-Aviv University Ltd. |
Compositions and methods for the treatment of tuberculosis
|
|
US12385054B2
(en)
|
2019-11-19 |
2025-08-12 |
Protalix Ltd. |
Removal of constructs from transformed cells
|
|
IL272389A
(en)
|
2020-01-30 |
2021-08-31 |
Yeda Res & Dev |
Kits containing antibodies to PD-L1 and their uses in therapy
|
|
EP4225903A1
(de)
|
2020-10-07 |
2023-08-16 |
Protalix Ltd. |
Langwirkende dnase
|
|
IL278401A
(en)
|
2020-10-29 |
2022-05-01 |
Yeda Res & Dev |
Polynucleotides for editing RNA and a method for using them
|
|
IL304916A
(en)
|
2021-02-05 |
2023-10-01 |
Salubris Biotherapeutics Inc |
Il-15 fusion proteins and methods of making and using same
|
|
EP4380973A2
(de)
|
2021-08-02 |
2024-06-12 |
Yeda Research and Development Co. Ltd. |
Anti-matrix-metalloproteinase-14-antikörper zur behandlung von krebs
|
|
AU2023233680A1
(en)
|
2022-03-15 |
2024-10-17 |
Salubris Biotherapeutics, Inc. |
Methods of treating fibrosis and arrhythmia with a neuregulin-1 fusion protein
|
|
WO2023209708A1
(en)
|
2022-04-25 |
2023-11-02 |
Yeda Research And Development Co. Ltd. |
Compositions for altering cyclic adp-ribose secondary messenger signalling
|
|
AU2024238898A1
(en)
|
2023-03-22 |
2025-10-16 |
Salubris Biotherapeutics, Inc. |
Anti-5t4 antigen binding domains, antibody-drug conjugates and methods of use thereof
|
|
WO2025215636A1
(en)
|
2024-04-08 |
2025-10-16 |
Yeda Research And Development Co. Ltd. |
Anti-defense system polypeptides and uses thereof
|
|
TW202612723A
(zh)
|
2024-05-21 |
2026-04-01 |
美商信立泰生物醫藥公司 |
神經調節蛋白-1 her3融合蛋白及其治療用途
|